ID23373A - PHARMACEUTICAL COMPOSITIONS THAT CONTAIN N-SULFONYLINDOLIN DEPOSITS - Google Patents

PHARMACEUTICAL COMPOSITIONS THAT CONTAIN N-SULFONYLINDOLIN DEPOSITS

Info

Publication number: ID23373A
Authority: ID; Indonesia
Prior art keywords: sulfonylindolin; deposits; contain; pharmaceutical compositions; pharmaceutical
Prior art date: 1996-12-05

Application number

IDW990445D

Other languages

Indonesian (id)

Inventor

Jean-Claude Gautier

Simon John Fuller

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-05

Filing date

1997-12-04

Publication date

2000-04-20

1997-12-04 Application filed by Sanofi Sa filed Critical Sanofi Sa

2000-04-20 Publication of ID23373A publication Critical patent/ID23373A/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Dispersion Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

IDW990445D 1996-12-05 1997-12-04 PHARMACEUTICAL COMPOSITIONS THAT CONTAIN N-SULFONYLINDOLIN DEPOSITS ID23373A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9614957A FR2756736B1 (en)	1996-12-05	1996-12-05	PHARMACEUTICAL COMPOSITIONS CONTAINING N-SULFONYL INDOLINE DERIVATIVES

Publications (1)

Publication Number	Publication Date
ID23373A true ID23373A (en)	2000-04-20

Family

ID=9498376

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW990445D ID23373A (en)	1996-12-05	1997-12-04	PHARMACEUTICAL COMPOSITIONS THAT CONTAIN N-SULFONYLINDOLIN DEPOSITS

Country Status (25)

Country	Link
EP (1)	EP0941090A1 (en)
JP (1)	JP2000507618A (en)
KR (1)	KR20000069308A (en)
CN (1)	CN1239887A (en)
AR (1)	AR009651A1 (en)
AU (1)	AU716575B2 (en)
BR (1)	BR9712406A (en)
CA (1)	CA2273990A1 (en)
CO (1)	CO4910129A1 (en)
DZ (1)	DZ2362A1 (en)
EE (1)	EE9900206A (en)
FR (1)	FR2756736B1 (en)
HU (1)	HUP0001386A3 (en)
ID (1)	ID23373A (en)
IL (1)	IL129936A0 (en)
IS (1)	IS5062A (en)
MY (1)	MY132819A (en)
NO (1)	NO992724D0 (en)
NZ (1)	NZ335750A (en)
RU (1)	RU2174394C2 (en)
SK (1)	SK75599A3 (en)
TR (1)	TR199901702T2 (en)
WO (1)	WO1998024430A1 (en)
YU (1)	YU23099A (en)
ZA (1)	ZA9710919B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2786486B3 (en) *	1998-11-16	2000-12-08	Sanofi Sa	PROCESS FOR THE PREPARATION OF (2S) -1 - [(2R, 3S) -5-CHLORO-3- (2- CHLOROPHENYL) -1- (3,4-DIMETHOXY BENZENESULFONYL) -3-HYDROXY- 2,3-DIHYDRO- 1H-INDOLE-2-CARBONYL] PYRROLIDINE-2-CARBOXAMIDE, ITS SOLVATES AND / OR HYDRATES
DE19913692A1 (en) *	1999-03-25	2000-09-28	Basf Ag	Mechanically stable pharmaceutical dosage forms containing liquid or semi-solid surface-active substances
US6437006B1 (en)	1999-09-27	2002-08-20	American Cyanamid Company	Pharmaceutical carrier formulation
CA2359945C (en)	1999-11-12	2011-04-26	Abbott Laboratories	Inhibitors of crystallization in a solid dispersion
FR2805992A1 (en) *	2000-03-08	2001-09-14	Sanofi Synthelabo	Oral administration of N-sulfonyl-indoline derivative to treat central nervous system, cardiovascular or gastric disorders, using polyethylene glycol, polysorbate and poloxamer as solubilizers for high bioavailability
DE10026698A1 (en)	2000-05-30	2001-12-06	Basf Ag	Self-emulsifying active ingredient formulation and use of this formulation
ITMI20011338A1 (en)	2001-06-26	2002-12-26	Farmatron Ltd	ORAL PHARMACEUTICAL COMPOSITIONS WITH IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
UA119324C2 (en) *	2013-04-02	2019-06-10	Теміс Медікер Лімітед	Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
KR102139339B1 (en) *	2013-06-24	2020-07-29	주식회사 엘지생활건강	Cosmetic composition which has improved solubility comprising indole compound
KR102139338B1 (en) *	2013-06-24	2020-07-29	주식회사 엘지생활건강	Cosmetic composition which has improved solubility comprising indole compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3237814A1 (en) *	1982-10-12	1984-04-12	Warner-Lambert Co., 07950 Morris Plains, N.J.	WATER-FREE EMULSIONS AND USE THEREOF
FR2679903B1 (en) *	1991-08-02	1993-12-03	Elf Sanofi	DERIVATIVES OF N-SULFONYL INDOLINE CARRYING AN AMIDIC FUNCTION, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.

1996
- 1996-12-05 FR FR9614957A patent/FR2756736B1/en not_active Expired - Fee Related
1997
- 1997-12-03 DZ DZ970212A patent/DZ2362A1/en active
- 1997-12-04 SK SK755-99A patent/SK75599A3/en unknown
- 1997-12-04 TR TR1999/01702T patent/TR199901702T2/en unknown
- 1997-12-04 KR KR1019997004983A patent/KR20000069308A/en not_active Application Discontinuation
- 1997-12-04 ZA ZA9710919A patent/ZA9710919B/en unknown
- 1997-12-04 WO PCT/FR1997/002210 patent/WO1998024430A1/en not_active Application Discontinuation
- 1997-12-04 CO CO97071118A patent/CO4910129A1/en unknown
- 1997-12-04 RU RU99114019/14A patent/RU2174394C2/en active
- 1997-12-04 EP EP97950228A patent/EP0941090A1/en not_active Withdrawn
- 1997-12-04 BR BR9712406-0A patent/BR9712406A/en unknown
- 1997-12-04 NZ NZ335750A patent/NZ335750A/en unknown
- 1997-12-04 EE EEP199900206A patent/EE9900206A/en unknown
- 1997-12-04 MY MYPI97005848A patent/MY132819A/en unknown
- 1997-12-04 HU HU0001386A patent/HUP0001386A3/en unknown
- 1997-12-04 AU AU53262/98A patent/AU716575B2/en not_active Ceased
- 1997-12-04 CN CN97180304A patent/CN1239887A/en active Pending
- 1997-12-04 IL IL12993697A patent/IL129936A0/en unknown
- 1997-12-04 CA CA002273990A patent/CA2273990A1/en not_active Abandoned
- 1997-12-04 AR ARP970105696A patent/AR009651A1/en unknown
- 1997-12-04 ID IDW990445D patent/ID23373A/en unknown
- 1997-12-04 JP JP10525294A patent/JP2000507618A/en active Pending
1999
- 1999-05-26 YU YU23099A patent/YU23099A/en unknown
- 1999-06-01 IS IS5062A patent/IS5062A/en unknown
- 1999-06-04 NO NO992724A patent/NO992724D0/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
SK75599A3 (en)	2000-08-14
AU716575B2 (en)	2000-03-02
BR9712406A (en)	1999-08-31
HUP0001386A2 (en)	2001-04-28
DZ2362A1 (en)	2002-12-28
CO4910129A1 (en)	2000-04-24
NO992724L (en)	1999-06-04
RU2174394C2 (en)	2001-10-10
EP0941090A1 (en)	1999-09-15
AR009651A1 (en)	2000-04-26
EE9900206A (en)	1999-12-15
ZA9710919B (en)	1999-06-04
FR2756736B1 (en)	1999-03-05
MY132819A (en)	2007-10-31
NZ335750A (en)	2001-06-29
IS5062A (en)	1999-06-01
HUP0001386A3 (en)	2002-03-28
CA2273990A1 (en)	1998-06-11
JP2000507618A (en)	2000-06-20
WO1998024430A1 (en)	1998-06-11
FR2756736A1 (en)	1998-06-12
CN1239887A (en)	1999-12-29
NO992724D0 (en)	1999-06-04
KR20000069308A (en)	2000-11-25
AU5326298A (en)	1998-06-29
IL129936A0 (en)	2000-02-29
TR199901702T2 (en)	1999-09-21
YU23099A (en)	1999-11-22

Publication	Publication Date	Title
IS4706A (en)	1998-03-31	pharmaceutical compositions
FI974241A0 (en)	1997-11-14	BPM-15 compositions
ID18352A (en)	1998-04-02	PHARMACEUTICAL COMPOSITIONS
MA24652A1 (en)	1999-04-01	CLEANING COMPOSITIONS
ATE209959T1 (en)	2001-12-15	MICRO-ENCAPSULED COMPOSITIONS
NO981568D0 (en)	1998-04-06	Randtennings-priming compositions
DE69719442D1 (en)	2003-04-10	Frisierschaum compositions
ATE293672T1 (en)	2005-05-15	COLOR-FRIENDLY COMPOSITIONS
DE69521804D1 (en)	2001-08-23	CLEANING COMPOSITIONS
DE69617029D1 (en)	2001-12-20	ORGANOTON COMPOSITIONS
ID23373A (en)	2000-04-20	PHARMACEUTICAL COMPOSITIONS THAT CONTAIN N-SULFONYLINDOLIN DEPOSITS
DE69708859T2 (en)	2002-04-11	CLEANING COMPOSITIONS
EE9800400A (en)	1999-06-15	Pharmaceutical compositions containing diclofenac
BR9707789A (en)	1999-07-27	Cleaning compositions comprising endo-dextranase
IS5184A (en)	1999-09-17	pharmaceutical compositions
PT941100E (en)	2003-10-31	PHARMACEUTICAL COMPOSITIONS
EE200000330A (en)	2001-08-15	Pharmaceutical compositions
ITMI942166A0 (en)	1994-10-21	PHARMACEUTICAL COMPOSITIONS MIORELAXANTS
ID23429A (en)	2000-04-20	SOLID SERTRALINA COMPOSITIONS
MA23731A1 (en)	1996-07-01	DETEGENT COMPOSITIONS
DE906393T1 (en)	2000-04-20	ULTRAMILDE CLEANING COMPOSITIONS
EE9800168A (en)	1998-12-15	Solid compositions
NO970747D0 (en)	1997-02-18	compositions
FI962738A (en)	1996-07-03	Pharmaceutical compositions
NO994436L (en)	1999-09-13	Pharmaceutical compositions